Xeris Biopharma Holdings Cash Flow Statement (2020-2026) | XERS

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-27.52M-26.01M-50.79M-33.71M-26.18M-21.83M-12.93M-16.83M-19.84M-12.19M-13.39M-18.98M-15.01M-15.74M-5.11M-9.22M-1.93M0.62M11.08M2.23M
Share-based Compensation (Quarter)
2.51M3.67M2.74M3.30M3.15M2.94M2.77M2.56M2.93M2.46M2.77M3.77M4.23M6.77M3.60M4.44M5.01M7.64M5.27M4.14M
Deferred Taxes (Quarter)
-0.68M0.68M-1.25M0.31M0.75M-3.32M
Gains from Investment Securities (Quarter)
-0.08M0.42M-0.24M0.86M20.04M0.05M3.43M0.05M0.08M0.17M8.00M0.86M0.48M1.54M17.02M
Cash from Operations (Quarter)
-20.02M-22.61M-28.95M-48.41M-20.61M-17.75M-16.12M-26.14M-13.74M-14.61M7.47M-20.30M-10.35M-8.30M1.98M-10.03M0.18M18.43M20.04M9.87M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.41M2.71M2.71M2.71M-0.04M2.71M2.71M2.71M-7.30M0.18M2.71M2.71M-7.38M0.12M2.71M2.71M0.54M0.16M
Amortization of Deferred Charges (Quarter)
0.20M0.20M0.23M0.22M0.50M0.40M0.45M0.50M0.60M0.60M0.50M0.57M0.80M0.80M0.80M0.80M0.80M0.80M0.87M0.90M
Depreciation & Amortization (CF) (Quarter)
0.32M0.32M0.35M0.32M0.35M0.36M0.37M0.36M0.39M0.39M0.35M0.33M0.28M0.31M0.31M0.32M0.33M0.34M0.34M0.34M
Change in Working Capital
Change in Receivables (Quarter)
3.36M1.27M-0.45M5.93M2.37M1.76M3.31M0.03M-0.64M15.74M-6.77M-1.78M5.03M-1.30M-0.72M5.92M6.72M0.70M-2.70M5.25M
Change in Inventory (Quarter)
0.40M1.26M2.27M0.16M0.15M1.66M5.50M3.82M7.43M2.15M1.40M2.33M2.27M1.05M3.14M3.62M7.57M4.08M4.01M-0.85M
Change in Account Payables (Quarter)
0.42M-0.90M4.35M2.17M-4.46M-2.71M0.69M6.93M0.08M0.30M-0.35M-4.47M-1.59M1.65M-5.20M4.06M-4.43M2.00M-1.70M4.25M
Change in Accured Expenses (Quarter)
2.83M0.02M-1.25M-2.69M-9.79M9.98M-8.89M-13.93M15.61M-0.24M1.95M0.80M1.03M-2.43M4.25M1.36M-0.27M0.30M2.33M-4.68M
Other Working Capital Changes (Quarter)
-0.96M1.33M-0.39M0.06M-0.06M-0.90M1.23M-2.05M-0.34M-2.04M0.76M0.30M0.30M-1.28M-1.53M0.79M4.09M-1.25M-0.14M
Investing Activities
Capital Expenditures (Quarter)
0.13M
Change in Acquisitions & Divestments (Quarter)
29.00M29.45M10.50M6.70M12.10M6.88M9.30M10.00M15.00M15.00M5.00M10.00M15.00M10.24M
Cash from Investing Activities (Quarter)
16.56M18.50M36.60M6.72M11.87M6.71M9.17M-43.98M8.45M14.65M14.87M-19.65M4.60M9.91M10.02M-0.01M-0.28M-0.07M-0.33M-0.33M
Financing Activities
Other financing activities (Quarter)
0.05M-0.05M3.60M1.06M0.16M0.06M1.19M
Cash from Financing Activities (Quarter)
0.46M0.00M0.12M78.19M0.31M-0.19M49.16M-0.86M0.56M-0.07M-1.23M35.19M0.66M-0.08M0.40M-3.14M0.94M13.85M-0.27M-8.84M
Additional items
Exchange Rate Effect (Quarter)
0.00M-0.00M-0.00M-0.00M0.00M
Change in Cash (Quarter)
-3.00M-4.11M7.78M36.50M-8.43M-11.23M42.20M-70.98M-4.74M-0.03M21.11M-4.76M-5.09M1.53M12.39M-13.18M0.84M32.21M19.44M0.71M
Free Cash Flow (Quarter)
-20.02M-22.61M-29.08M-48.41M-20.61M-17.75M-16.12M-26.14M-13.74M-14.61M7.47M-20.30M-10.35M-8.30M1.98M-10.03M0.18M18.43M20.04M9.87M
Net Cash Flow (Quarter)
-3.01M-4.11M7.78M36.50M-8.43M-11.23M42.20M-70.98M-4.74M-0.03M21.11M-4.76M-5.09M1.53M12.39M-13.18M0.84M32.21M19.44M0.71M